. .
.
. Mayo Clinic Health Solutions
.
. .
.
Search:
Browse Categories:
  arrow Research Tools
arrow
  arrow Diagnostics
arrow
  arrow Therapeutics
arrow
  arrow Medical Devices
arrow
  arrow Electronic Devices
arrow
  arrow Software
arrow
  arrow All Listings
arrow
arrow
  Home
arrow
  About Us
arrow
  Contact Us
arrow
arrow
  Go to mayoclinic.org
arrow
  Go to Research at Mayo Clinic
arrow
Mayo Clinic Technology
.

Novel Oxime-Based Cholinesterase Reactivators as Antidotes for Organophosphates

Reference #:

1997-053

Inventors/Contributors

Yuan-Ping Pang, Ph.D., Stephen W. Brimijoin, Ph.D.

Description

An efficient and economical synthesis for novel oxime analogs yields analogs that are up to 100-fold more effective in reactivating the OFP-poisoned acetylcholinesterase than the standard clinical drug 2-pralidoxime. The analogs can be used as effective and economical antidotes for organophosphates poisoning, to treat accidental organophosphate-pesticide poisoning, and to counter actual and potential terrorist use of organophosphates.

Patent Status

button

U.S. Patent Number 5,929,093
Issued July 27, 1999

Contact

Nathan L. Stacy, Licensing Manager
stacy.nathan@mayo.edu

Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905

Phone: (507) 538-1652
Fax: (507) 284-5410